Published in Eur Arch Otorhinolaryngol on February 14, 2013
Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study. Biomed Res Int (2015) 0.79
A review of current progress in acquired cholesteatoma management. Eur Arch Otorhinolaryngol (2014) 0.77
[Mastoidectomy - biphasic ceramics as a filler is advantageous]. Laryngorhinootologie (2014) 0.75
Canal wall reconstruction in cholesteatoma surgeries: rate of residual. Eur Arch Otorhinolaryngol (2014) 0.75
Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. J Biomed Mater Res (1989) 1.85
A review of bioceramics and fibrin sealant. Eur Cell Mater (2004) 1.59
Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng (2005) 1.47
Calcium phosphate materials in restorative dentistry: a review. Adv Dent Res (1988) 1.38
Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials (1998) 1.35
Formation of carbonate-apatite crystals after implantation of calcium phosphate ceramics. Calcif Tissue Int (1990) 1.26
Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. J Biomed Mater Res (1990) 1.24
Operative technique in mastoid obliteration. Acta Otolaryngol (1973) 1.07
Mastoid obliteration: autogenous cranial bone pAte reconstruction. Otol Neurotol (2003) 1.02
Surgical modification of the difficult mastoid cavity. Otolaryngol Head Neck Surg (1999) 0.98
Surgical management of the discharging mastoid cavity. J Laryngol Otol Suppl (1988) 0.93
Extensive cholesteatoma: long-term results of three surgical techniques. J Laryngol Otol (1997) 0.92
Mastoid and epitympanic bony obliteration in pediatric cholesteatoma. Otol Neurotol (2008) 0.92
A ten year statistical follow-up of 1142 consecutive cases of cholesteatoma: the closed vs. the open technique. Laryngoscope (1982) 0.90
Biphasic ceramics and fibrin sealant for bone reconstruction in ear surgery. Ann Otol Rhinol Laryngol (2004) 0.90
Mastoidectomy cavity obliteration with bioactive glass: a pilot study. Otolaryngol Head Neck Surg (2012) 0.90
Macroporous biphasic calcium phosphate efficiency in mastoid cavity obliteration: experimental and clinical findings. Ann Otol Rhinol Laryngol (1992) 0.88
Rehabilitation of canal wall down mastoidectomy using a titanium ear canal implant. Otol Neurotol (2010) 0.88
Addition of fibrin sealant to ceramic promotes bone repair: long-term study in rabbit femoral defect model. J Biomed Mater Res (1998) 0.87
Hydroxyapatite canal wall reconstruction/mastoid obliteration. Otolaryngol Head Neck Surg (1999) 0.86
Mastoid obliteration with silicone blocks after canal wall down mastoidectomy. Clin Exp Otorhinolaryngol (2012) 0.86
Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Ann Otol Rhinol Laryngol (2012) 0.82
Results of cavity reconstruction with hydroxyapatite implants after 15 years. Am J Otol (1998) 0.82
A technique for the reconstruction of the posterior canal wall and mastoid obliteration in radical cavity surgery. Am J Otol (1990) 0.81
Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Ann Otol Rhinol Laryngol (2010) 0.81
Micro macroporous biphasic ceramics and fibrin sealant as a moldable material for bone reconstruction in chronic otitis media surgery. A 15 years experience. J Mater Sci Mater Med (2003) 0.80
Mastoid obliteration with bone. Otolaryngol Clin North Am (1972) 0.80
Modified canal wall-up mastoidectomy with mastoid obliteration for severe chronic otitis media. ORL J Otorhinolaryngol Relat Spec (1995) 0.79
In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant. Arch Orthop Trauma Surg (2005) 0.79
Use of autologous osteocyte containing bone pate for closure of tegmental defects. Am J Otol (1998) 0.78
Effects of mastoid cavity obliteration on the growth of experimentally produced residual cholesteatoma. Acta Otolaryngol (1998) 0.78
Bone pâté obliteration or revision mastoidectomy: a five-symptom comparative study. Clin Otolaryngol Allied Sci (1994) 0.76
Biofunctionality of MBCP ceramic granules (TricOs) plus fibrin sealant (Tisseel) versus MBCP ceramic granules as a filler of large periprosthetic bone defects: an investigative ovine study. J Mater Sci Mater Med (2010) 0.75
Preservation of residual hearing with cochlear implantation: how and why. Acta Otolaryngol (2005) 1.93
Consensus statements on the BAHA system: where do we stand at present? Ann Otol Rhinol Laryngol Suppl (2005) 1.85
Residual hearing conservation and electroacoustic stimulation with the nucleus 24 contour advance cochlear implant. Otol Neurotol (2006) 1.66
Factors affecting auditory performance of postlinguistically deaf adults using cochlear implants: an update with 2251 patients. Audiol Neurootol (2012) 1.38
Management of cholesterol granulomas of the petrous apex based on clinical and radiologic evaluation. Otol Neurotol (2002) 1.36
Pre-, per- and postoperative factors affecting performance of postlinguistically deaf adults using cochlear implants: a new conceptual model over time. PLoS One (2012) 1.34
European multi-centre study of the Nucleus Hybrid L24 cochlear implant. Int J Audiol (2013) 1.23
Design, kinematic optimization, and evaluation of a teleoperated system for middle ear microsurgery. ScientificWorldJournal (2012) 1.19
Evaluation of the management of postoperative aseptic meningitis. Clin Infect Dis (2007) 1.15
Cardiovascular and thromboembolic risk factors in idiopathic sudden sensorineural hearing loss: a case-control study. Audiol Neurootol (2010) 1.14
Diagnosis and management of intracochlear schwannomas. Otol Neurotol (2007) 1.11
Speech performance and sound localization in a complex noisy environment in bilaterally implanted adult patients. Audiol Neurootol (2008) 1.09
Plastin 1 binds to keratin and is required for terminal web assembly in the intestinal epithelium. Mol Biol Cell (2009) 1.06
Combined electroacoustic stimulation in conventional candidates for cochlear implantation. Audiol Neurootol (2006) 1.06
Multicenter evaluation of the digisonic SP cochlear implant fixation system with titanium screws in 156 patients. Ann Otol Rhinol Laryngol (2010) 1.05
What's new in ion transports in the cochlea? Pflugers Arch (2006) 1.03
Cochlear implant insertion forces in microdissected human cochlea to evaluate a prototype array. Audiol Neurootol (2012) 1.01
Benefit of the Vibrant Soundbridge device in patients implanted for 5 to 8 years. Ear Hear (2008) 0.99
Results from a European clinical investigation of the Nucleus multichannel auditory brainstem implant. Ear Hear (2002) 0.98
Temperature-sensitive auditory neuropathy associated with an otoferlin mutation: Deafening fever! Biochem Biophys Res Commun (2010) 0.97
Friction force measurement during cochlear implant insertion: application to a force-controlled insertion tool design. Otol Neurotol (2012) 0.96
Literature review of questionnaires assessing vertigo and dizziness, and their impact on patients' quality of life. Value Health (2007) 0.95
High variability of perilymphatic entry of neutral molecules through the round window. Acta Otolaryngol (2003) 0.94
Evolution of electrode array diameter for hearing preservation in cochlear implantation. Acta Otolaryngol (2012) 0.91
Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients. Otol Neurotol (2008) 0.91
Functional results of Vibrant Soundbridge middle ear implants in conductive and mixed hearing losses. Audiol Neurootol (2011) 0.89
Effects of systemic administration of methylprednisolone on residual hearing in an animal model of cochlear implantation. Acta Otolaryngol (2010) 0.89
Middle ear and mastoid obliteration for cochlear implant in adults: indications and anatomical results. Otol Neurotol (2015) 0.88
Diode laser in otosclerosis surgery: first clinical results. Otol Neurotol (2008) 0.88
Minimally invasive computer-assisted approach for cochlear implantation: a human temporal bone study. Surg Innov (2011) 0.87
Hearing preservation after cochlear implantation using deeply inserted flex atraumatic electrode arrays. Audiol Neurootol (2012) 0.87
Epithelium expression and function of retinoid receptors in asthma. Am J Respir Cell Mol Biol (2007) 0.87
Benefits from upgrade to the CP810 sound processor for Nucleus 24 cochlear implant recipients. Eur Arch Otorhinolaryngol (2013) 0.87
Conservative management versus surgery for small vestibular schwannomas. Acta Otolaryngol (2005) 0.87
Cochlear implant benefits in deafness rehabilitation: PET study of temporal voice activations. J Nucl Med (2007) 0.86
Glucocorticoids inhibit diastrophic dysplasia sulfate transporter activity in otosclerosis by interleukin-6. Laryngoscope (2006) 0.86
Auditory brainstem implant in bilateral and completely ossified cochleae. Otol Neurotol (2003) 0.86
Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Otol Neurotol (2008) 0.86
A Retrospective Multicenter Study Comparing Speech Perception Outcomes for Bilateral Implantation and Bimodal Rehabilitation. Ear Hear (2015) 0.86
Use of anatomic or invasive markers in association with skin surface registration in image-guided surgery of the temporal bone. Acta Otolaryngol (2009) 0.85
Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol (2012) 0.84
Cochlear implants in elderly people: preliminary results. Acta Otolaryngol Suppl (2004) 0.84
Functional IsK/KvLQT1 potassium channel in a new corticosteroid-sensitive cell line derived from the inner ear. J Biol Chem (2006) 0.84
Long-term functional outcome in facial nerve graft by fibrin glue in the temporal bone and cerebellopontine angle. Eur Arch Otorhinolaryngol (2004) 0.84
Four-channel electromyography of the facial nerve in vestibular schwannoma surgery: sensitivity and prognostic value for short-term facial function outcome. Otol Neurotol (2005) 0.84
Assessment of 'Fitting to Outcomes Expert' FOX™ with new cochlear implant users in a multi-centre study. Cochlear Implants Int (2014) 0.84
Visual analog scale to assess vertigo and dizziness after repositioning maneuvers for benign paroxysmal positional vertigo. J Vestib Res (2011) 0.84
Do facial nerve displacement pattern and tumor adhesion influence the facial nerve outcome in vestibular schwannoma surgery? Otol Neurotol (2009) 0.83
Intact blood-perilymph barrier in the rat after impulse noise trauma. Acta Otolaryngol (2008) 0.83
Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line. Mol Endocrinol (2009) 0.83
Intraoperative electromyography and surgical observations as predictive factors of facial nerve outcome in vestibular schwannoma surgery. Otol Neurotol (2010) 0.83
Effect of repositioning maneuver type and postmaneuver restrictions on vertigo and dizziness in benign positional paroxysmal vertigo. ScientificWorldJournal (2012) 0.83
Clinical and Histologic Parameters Correlated with Facial Nerve Function After Vestibular Schwannoma Surgery. Skull Base (2003) 0.82
Validation method of a middle ear mechanical model to develop a surgical simulator. Audiol Neurootol (2013) 0.81
Effect of angiotensin II on inflammation pathways in human primary bone cell cultures in otosclerosis. Audiol Neurootol (2012) 0.81
Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. Neurosurgery (2013) 0.81
Ossiculoplasty with total hydroxylapatite prostheses anatomical and functional outcomes. Otol Neurotol (2003) 0.81
Use of bone anchoring device in electromagnetic computer-assisted navigation in lateral skull base surgery. Acta Otolaryngol (2013) 0.80